GGrantIndex
Sort

40,608 grants matching prostate cancer

REGULATION OF PROSTATE CANCER BONE METASTASIS BY DKK1

$331,867
University Of Alabama At Birmingham · · FY2008 · Department of Defense

Hyaluronic Acid Based Nanoparticles for Targeted Image-Guided Tumor Surgery

$331,852
Aaron M. Mohs · University Of Nebraska Medical Center · R01 · FY2015 · EB

Cancer Vaccines and Modulation of Checkpoint Controls in Immunization

$331,812
John Janik · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA

Vitamin D and Dexamethasone in Myelodysplastic Syndromes

$331,803
University Of Pittsburgh At Pittsburgh · R21 · FY2003 · CA

Lymphatic Imaging

$331,775
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Administrative Core

$331,744
Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2025 · CA

Identifying and Targeting Specific Determinants of the AR Cistrome that Drive Prostate Cancer Cell Survival and Proliferation

$331,743
Peter S Nelson · Beth Israel Deaconess Medical Center · P01 · FY2025 · CA

Identify Mechanisms Driving Resistance to AR Antagonists in CRPC

$331,743
Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2025 · CA

Functional Interplay Between PARP, AR and DNA Damage

$331,742
Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2025 · CA

PDX/Biospecimen Core

$331,742
Eva Corey · Beth Israel Deaconess Medical Center · P01 · FY2025 · CA

Functional Epigenetics Core

$331,742
Henry W. Long · Beth Israel Deaconess Medical Center · P01 · FY2025 · CA

Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment

$331,736
Peisheng Xu · University Of South Carolina At Columbia · R01 · FY2023 · CA

ROLE OF FOXM1 IN THE PATHOGENESIS OF PROSTATE CANCER

$331,718
Childrens Hospital Medical Center · · FY2009 · Department of the Army

Androgen Deprivation Activates Wnt/Beta-Catenin Signaling in Prostate Cancer

$331,688
Xiuping Yu · Louisiana State Univ Hsc Shreveport · R01 · FY2018 · CA

Androgen Deprivation Activates Wnt/Beta-Catenin Signaling in Prostate Cancer

$331,688
Xiuping Yu · Louisiana State Univ Hsc Shreveport · R01 · FY2021 · CA

Androgen Deprivation Activates Wnt/Beta-Catenin Signaling in Prostate Cancer

$331,688
Xiuping Yu · Louisiana State Univ Hsc Shreveport · R01 · FY2020 · CA

Systematic Genetic Characterization of African American Prostate Cancer

$331,631
Levi Alexander Garraway · Dana-Farber Cancer Inst · U01 · FY2014 · CA

PROSTATE CANCER CHEMOPREVENTION CLINICAL TRIALS

$331,604
New York University School Of Medicine · U01 · FY2001 · CA

EVALUATING THE ROLE OF WEARABLE TECHNOLOGY AND PATIENT-REPORTED OUTCOMES TO MONITOR PHYSICAL FUNCTION DECLINE IN PROSTATE CANCER SURVIVORS

$331,588
Cedars-Sinai Medical Center · · FY2020 · Department of the Army

Diagnostic Therapeutic Targets in Prostate Cancer

$331,525
Cleveland Clinic Foundation · R01 · FY2003 · CA

Regulation of prostate epithelial basal cell plasticity

$331,515
Zhu Wang · University Of California Santa Cruz · R01 · FY2023 · CA

Molecular Changes Associated with PCa bone metastases

$331,504
Kenneth J. Pienta · University Of Michigan At Ann Arbor · R01 · FY2006 · CA

Assembly of phi29 pRNA nanoparticles for siRNA delivery to prostate cancer cells

$331,475
Peixuan Guo · University Of Cincinnati · R01 · FY2010 · EB

THE GENETIC EPIDEMIOLOGY OF COMPLEX TRAITS

$331,467
University Of Washington · R01 · FY2003 · GM

Computational Design of Protein-Ligand Interfaces - a Therapeutic Strategy

$331,459
Jens Meiler · Vanderbilt University · R01 · FY2014 · GM